Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Basal Cell Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002963
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Roswell Park Cancer Institute
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Ended earlyNCT02956889
What this trial is testing

To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
Istituto Clinico Humanitas 14
Not applicableStudy completedNCT05126173
What this trial is testing

DERM US and EU Validation Study

Who this might be right for
Malignant Skin Melanoma T0Basal Cell CarcinomaSquamous Cell Carcinoma
Skin Analytics Limited 1,111
Not applicableStudy completedNCT03836105
What this trial is testing

CemiplimAb Survivorship Epidemiology

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 287
Testing effectiveness (Phase 2)UnknownNCT06409195
What this trial is testing

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Who this might be right for
Non-Melanoma Skin Cancers
DermBiont, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00066872
What this trial is testing

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Queen's Medical Center 500
Not applicableStudy completedNCT02939027
What this trial is testing

Study of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
Instituto de Investigacion Sanitaria La Fe 40
Testing effectiveness (Phase 2)UnknownNCT04362722
What this trial is testing

Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Who this might be right for
Carcinoma, Basal CellCarcinoma, Cutaneous Squamous Cell
Philogen S.p.A. 40
Not applicableStudy completedNCT01212562
What this trial is testing

Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery

Who this might be right for
Basal Cell Carcinoma
University of Ioannina 70
Not applicableStudy completedNCT01498250
What this trial is testing

Microarray Analysis of microRNA Expression in Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Ruhr University of Bochum 7
Not applicableStudy completedNCT02157623
What this trial is testing

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Edward Maytin, MD, PhD 3
Not applicableUnknownNCT06342297
What this trial is testing

Dermatoscopy Guided Resection for Skin Cancer

Who this might be right for
Basal Cell CarcinomaCutaneous Squamous Cell CarcinomaSurgical Margin
Region Örebro County 400
Testing effectiveness (Phase 2)Study completedNCT03035188
What this trial is testing

Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
SRH Wald-Klinikum Gera GmbH 40
Testing effectiveness (Phase 2)UnknownNCT01349361
What this trial is testing

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Who this might be right for
Photodynamic TherapyBasal Cell Carcinomas
Bispebjerg Hospital
Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Testing effectiveness (Phase 2)Study completedNCT00108121
What this trial is testing

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Peplin 60
Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing

Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27
Post-approval studies (Phase 4)Study completedNCT00314756
What this trial is testing

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Who this might be right for
Basal Cell Carcinoma
Wake Forest University 15
Next Page